Compare Merck Tbk. (MERK) vs Destinasi Tirta Nusantara Tbk (PDES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Destinasi Tirta Nusantara Tbk — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Destinasi Tirta Nusantara Tbk trades at Rp404 (market cap 290.29B, 1.2K 24h volume). The key difference: Merck Tbk. is far larger — about 5.9× Destinasi Tirta Nusantara Tbk's market cap, and Merck Tbk. is more actively traded (37.6K versus 1.2K). Which is the better fit depends on your goals.
| MERK | PDES | |
|---|---|---|
Market Cap | 1.7T | 290.29B |
Volume | 37.6K | 1.2K |
Lot | 376 | 12 |
Turnover | 144.47M | 482.8K |
Average Price | 3,842.23 | 402.33 |
Value | 144.47M | 482.8K |
Indicative Equilibrium Price | 3,840 | 404 |
Indicative Equilibrium Volume | 7 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Read more on PDES →
